Controlling the fractal dimension in self-assembly of terpyridine modified insulin by Fe2+ and Eu3+ to direct in vivo effects

Ca2+-Responsive Glyco-insulin

Chemical modification of peptides and proteins, such as PEGylation and lipidation, creates conjugates with new properties. However, they are typically not dynamic or stimuli-responsive. Self-assembly controlled by a stimulus will allow adjusting properties directly. Here, we report that conjugates of oligogalacturonic acids (OGAs), isolated from plant-derived pectin, are Ca²⁺-responsive. We report the conjugation of OGA to human insulin (HI) to create new glyco-insulins. In addition, we coupled OGA to model peptides. We studied their self-assembly by dynamic light scattering, small-angle X-ray scattering, and circular dichroism, which showed that the self-assembly to form nanostructures depended on the length of the OGA sequence and Zn²⁺ and Ca²⁺ concentrations. Subcutaneous administration of OGA12-HI with Zn²⁺ showed a stable decrease in blood glucose over a longer period of time compared to HI, despite the lower receptor binding affinity.

Dual-Ligand Near-Infrared Luminescent Lanthanide-Based Metal-Organic Framework Coupled with In Vivo Microdialysis for Highly Sensitive Ratiometric Detection of Zn2+ in a Mouse Model of Alzheimer's Disease

Zinc, which is the second most abundant trace element in the human central nervous system, is closely associated with Alzheimer's disease (AD). However, attempts to develop highly sensitive and selective sensing systems for Zn²⁺ in the brain have not been successful. Here, we used a one-step solvothermal method to design and prepare a metal-organic framework (MOF) containing the dual ligands, terephthalic acid (H₂BDC) and 2,2':6',2″-terpyridine (TPY), with Eu³⁺ as a metal node. This MOF is denoted as Eu-MOF/BDC-TPY. Adjustment of the size and morphology of Eu-MOF/BDC-TPY allowed the dual ligands to produce multiple luminescence peaks, which could be interpreted via ratiometric fluorescence to detect Zn²⁺ using the ratio of Eu³⁺-based emission, as the internal reference, and ligand-based emission, as the indicator. Thus, Eu-MOF/BDC-TPY not only displayed higher selectivity than other metal cations but also offered a highly accurate, sensitive, wide linear, color change-based technique for detecting Zn²⁺ at concentrations ranging from 1 nM to 2 μM, with a low limit of detection (0.08 nM). Moreover, Eu-MOF/BDC-TPY maintained structural stability and displayed a fluorescence intensity of at least 95.4% following storage in water for 6 months. More importantly, Eu-MOF/BDC-TPY sensed the presence of Zn²⁺ markedly rapidly (within 5 s), which was very useful in practical application. Furthermore, the results of our ratiometric luminescent method-based analysis of Zn²⁺ in AD mouse brains were consistent with those obtained using inductively coupled plasma mass spectrometry.

Metal-ion coordinated self-assembly of human insulin directs kinetics of insulin release as determined by preclinical SPECT/CT imaging

Human insulin (HI) has fascinating metal-facilitated self-assembly properties that are essential for its biological function. HI has a natural Zn²⁺ binding site and we have previously shown that covalently attached abiotic ligands (e.g., bipyridine, terpyridine) can lead to the formation of nanosized oligomeric structures through the coordination of metal ions. Here we studied the hypothesis that metal ions can be used to directly control the pharmacokinetics of insulin after covalent attachment of an abiotic ligand that binds metal ions. We evaluated the pharmacokinetics (PK) and biodistribution of HI self-assemblies directed by metal ion coordination (i.e., Fe²⁺/Zn²⁺, Eu³⁺/Zn²⁺, Fe²⁺/Co³⁺) using preclinical SPECT/CT imaging and ex vivo gamma counting. HI was site-specifically modified with terpyridine (Tpy) at the Phe^B1 or Lys^B29 position to create conjugates that bind either Fe²⁺ or Eu³⁺, while its natural binding site (e.g., His^B10) preferentially coordinates with either Zn²⁺ or Co³⁺. HI was also functionalized with trans-cyclooctene (TCO) opposite to Tpy at Phe^B1 or Lys^B29, respectively, to allow for tetrazine-TCO coupling via a tetrazine-modified DTPA followed by ¹¹¹In-radiolabeling for SPECT/CT imaging. When the ¹¹¹In-B29Tpy-HI conjugate was coordinated with Fe²⁺/Zn²⁺, its retention at the injection site 6 h after injection was ~8-fold higher than the control without the metal ions, while its kidney accumulation was lower. ¹¹¹In-B1Tpy-HI showed comparable retention at the injection site 6 h after injection and slightly increased retention at 24 h. However, higher kidney accumulation and residence time of degraded ¹¹¹In-B1Tpy-HI was observed compared to that of ¹¹¹In-B29Tpy-HI. Quantitative PK analysis based on SPECT/CT images confirmed slower distribution from the injection site of the HI-metal ion assemblies compared to control HI conjugates. Our results show that the Tpy-binding site (i.e., Phe^B1 or Lys^B29) on HI and its coordination with the added metal ions (i.e., Fe²⁺/Zn²⁺ or Fe²⁺/Co³⁺) directed the distribution half-life of HI significantly. This clearly indicates that the PK of insulin can be controlled by complexation with different metal ions.